Merck & Co. loses Temodar/Temodal/Temozolomide pat
Post# of 148122
(Total Views: 612)
Posted On: 02/01/2024 5:04:15 PM
Merck & Co. loses Temodar/Temodal/Temozolomide patent protection...the latter been used in concert with Leronlimab...in Glioblastoma..as pointed out on mice.
Are they trying to reinvent the Temo wheel?..
.My research finds RLS (EU) manufactures the drug...while Waverly Pharma owns the patent.?
U.S. Food and Drug Adminstration.
14 September 2023 Archived
(https://web.archive.org/web20230915015751/https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-new-and-updated-indications-temozolomide-under-project-renewal) from the original on 15 September 2023. Retrieved 14 September 2023.
Both products penetrate the BBB.
Are they trying to reinvent the Temo wheel?..
.My research finds RLS (EU) manufactures the drug...while Waverly Pharma owns the patent.?
U.S. Food and Drug Adminstration.
14 September 2023 Archived
(https://web.archive.org/web20230915015751/https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-new-and-updated-indications-temozolomide-under-project-renewal) from the original on 15 September 2023. Retrieved 14 September 2023.
Both products penetrate the BBB.
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼